Related Experiment Video
Updated: Jul 16, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Upregulation of NOR-1 in calcified human vascular tissues: impact on osteogenic differentiation and calcification
Carme Ballester-Servera1, Laia Cañes1, Judith Alonso1
1Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Barcelona, Spain; CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain; Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
Insights
NOR-1 protein was found to inhibit cardiovascular calcification by downregulating osteogenic genes in valvular interstitial cells and vascular smooth muscle cells. This discovery offers new insights into preventing ectopic calcification in cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Biochemistry
Background:
- Cardiovascular calcification is a major public health concern with incompletely understood mechanisms.
- The role of NOR-1 in ectopic calcification, particularly in the cardiovascular system, was previously unknown.
Purpose of the Study:
- To investigate the role of NOR-1 in cardiovascular calcification.
- To determine if NOR-1 influences the osteogenic differentiation of valvular interstitial cells (VICs) and vascular smooth muscle cells (VSMCs).
Main Methods:
- Overexpression of NOR-1 in human VICs and VSMCs.
- Gain- and loss-of-function studies in VICs and VSMCs.
- Analysis of osteogenic markers and calcification in transgenic mice (TgNOR-1VSMC) and wild-type (WT) littermates.
- Induction of atherosclerosis and calcification in mice using AAV-PCSK9D374Y and a high-fat/high-cholesterol diet.
Main Results:
- NOR-1 was overexpressed in human calcific aortic valves and atherosclerotic lesions, colocalizing with RUNX2.
- NOR-1 negatively modulated osteogenic gene expression (RUNX2, IL-6, BMP2, ALPL) and calcification in VICs.
- NOR-1 overexpression in VSMCs reduced basal osteogenic gene expression and prevented OM-induced calcification.
- TgNOR-1VSMC mice showed reduced vascular osteogenic markers, atherosclerotic burden, and vascular calcification compared to WT mice.
Conclusions:
- NOR-1 acts as a negative regulator of osteogenic differentiation in VICs and VSMCs.
- NOR-1 restrains ectopic cardiovascular calcification, suggesting a potential therapeutic target.
Abstract:
Cardiovascular calcification is a significant public health issue whose pathophysiology is not fully understood. NOR-1 regulates critical processes in cardiovascular remodeling, but its contribution to ectopic calcification is unknown. NOR-1 was overexpressed in human calcific aortic valves and calcified atherosclerotic lesions colocalizing with RUNX2, a factor essential for osteochondrogenic differentiation and calcification. NOR-1 and osteogenic markers were upregulated in calcifying human valvular interstitial cells (VICs) and human vascular smooth muscle cells (VSMCs). Gain- and loss-of-function approaches demonstrated that NOR-1 negatively modulates the expression of osteogenic genes relevant for the osteogenic transdifferentiation (RUNX2, IL-6, BMP2, and ALPL) and calcification of VICs. VSMCs from transgenic mice overexpressing NOR-1 in these cells (TgNOR-1VSMC) expressed lower basal levels of osteogenic genes (IL-6, BMP2, ALPL, OPN) than cells from WT littermates, and their upregulation by a high-phosphate osteogenic medium (OM) was completely prevented by NOR-1 transgenesis. Consistently, this was associated with a dramatic reduction in the calcification of both transgenic VSMCs and aortic rings from TgNOR-1VSMC mice exposed to OM. Atherosclerosis and calcification were induce in mice by the administration of AAV-PCSK9D374Y and a high-fat/high-cholesterol diet. Challenged-TgNOR-1VSMC mice exhibited decreased vascular expression of osteogenic markers, and both less atherosclerotic burden (assessed in whole aorta and lesion size in aortic arch and brachiocephalic artery) and less vascular calcification (assessed either by near-infrared fluorescence imaging or histological analysis) than WT mice. Our data indicate that NOR-1 negatively modulates the expression of genes critically involved in the osteogenic differentiation of VICs and VSMCs, thereby restraining ectopic cardiovascular calcification.
More Related Videos
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Related Concept Videos
Skeleton and Calcium Homeostasis
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Regulation of Angiogenesis and Blood Supply
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Osteoclasts in Bone Remodeling